Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Mereo BioPharma (MREO) over the last 5 years, with Q3 2025 value amounting to 0.01.

  • Mereo BioPharma's Asset Utilization Ratio fell 4910.22% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 4910.22%. This contributed to the annual value of 0.14 for FY2023, which is N/A changed from last year.
  • Per Mereo BioPharma's latest filing, its Asset Utilization Ratio stood at 0.01 for Q3 2025, which was down 4910.22% from 0.0 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma's Asset Utilization Ratio registered a high of 0.16 during Q1 2024, and its lowest value of 0.02 during Q2 2022.
  • Over the past 4 years, Mereo BioPharma's median Asset Utilization Ratio value was 0.0 (recorded in 2025), while the average stood at 0.02.
  • In the last 5 years, Mereo BioPharma's Asset Utilization Ratio plummeted by 3845.09% in 2021 and then plummeted by 10152.29% in 2025.
  • Mereo BioPharma's Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then decreased by 19.45% to 0.02 in 2022, then soared by 144.7% to 0.01 in 2024, then crashed by 49.1% to 0.01 in 2025.
  • Its Asset Utilization Ratio stands at 0.01 for Q3 2025, versus 0.0 for Q2 2025 and 0.0 for Q1 2025.